Literature DB >> 3882150

The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomerase.

G Fischer, H Bang.   

Abstract

The refolding of urea-denatured ribonuclease A was measured at 0.31-3.1 mol . l-1 urea in the presence of various concentrations of peptidyl-prolyl cis-trans isomerase isolated from pig kidney. The rate of the slow CT-phase in the refolding reaction was found to be sensitive to this enzyme. A rate enhancement proportional to the isomerase activity has been observed. The activity of the enzyme was assayed with Glt-Ala-Ala-Pro-Phe-4-nitroanilide. The catalytic activity of the isomerase against unfolded ribonuclease is suppressed after preincubation of the enzyme with 0.001 mol . l-1 Cu2+, 0.01 mol . l-1 H+ and by heat inactivation. The results indicate the involvement of the cis/trans interconversion of proline peptide bonds during the refolding of ribonuclease A.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882150     DOI: 10.1016/0167-4838(85)90006-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  28 in total

1.  Inhibition of liver, kidney, and intestine regeneration by rapamycin.

Authors:  A Francavilla; T E Starzl; C Scotti; G Carrieri; A Azzarone; Q H Zeng; K A Porter; S L Schreiber
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

2.  A Cyanobacterial Gene Encoding Peptidyl-Prolyl cis-trans Isomerase.

Authors:  M Hassidim; R Schwarz; J Lieman-Hurwitz; E Marco; M Ronen-Tarazi; A Kaplan
Journal:  Plant Physiol       Date:  1992-12       Impact factor: 8.340

3.  Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.

Authors:  J J Fung; S Todo; A Tzakis; A Demetris; A Jain; K Abu-Elmaged; M Alessiani; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

4.  Hepatotrophic effects of FK506 in dogs.

Authors:  T E Starzl; K A Porter; V Mazzaferro; S Todo; J Fung; A Francavilla
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

5.  Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.

Authors:  L Mieles; R D Gordon; D Mintz; R M Toussaint; O Imventarza; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

6.  Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506.

Authors:  A Francavilla; T E Starzl; M Barone; Q H Zeng; K A Porter; A Zeevi; P M Markus; M R van den Brink; S Todo
Journal:  Hepatology       Date:  1991-07       Impact factor: 17.425

7.  An endoplasmic reticulum-specific cyclophilin.

Authors:  K W Hasel; J R Glass; M Godbout; J G Sutcliffe
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

8.  Hepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycin.

Authors:  T E Starzl; S L Schreiber; M W Albers; K A Porter; C S Foglieni; A Francavilla
Journal:  Transplantation       Date:  1991-10       Impact factor: 4.939

9.  Urea's effect on the ribonuclease A catalytic efficiency: a kinetic, 1H NMR and molecular orbital study.

Authors:  Jorge Almarza; Luis Rincón; Alí Bahsas; María Angela Pinto; Francisco Brito
Journal:  Protein J       Date:  2013-02       Impact factor: 2.371

10.  Connective tissue alterations in Fkbp10-/- mice.

Authors:  Caressa D Lietman; Abbhirami Rajagopal; Erica P Homan; Elda Munivez; Ming-Ming Jiang; Terry K Bertin; Yuqing Chen; John Hicks; MaryAnn Weis; David Eyre; Brendan Lee; Deborah Krakow
Journal:  Hum Mol Genet       Date:  2014-04-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.